The Effect of Erector Spinae Plane Block (ESPB) on Pediatric Pain Management Following Posterior Spinal Fusion (PSF) Surgery

Purpose

This study is being done to better understand the efficacy of an erector spinae plane block (ESPB) in pain management for children with Adolescent Idiopathic Scoliosis or Neuromuscular Scoliosis undergoing Posterior Spinal Fusion surgery. The study team is trying to find out if receiving the ESPB leads to less pain and less need for pain medication after surgery. The ESPB involves an injection of a local anesthetic, ropivacaine, into your child's back muscles to help block pain signals.

Conditions

  • Adolescent Idiopathic Scoliosis (AIS)
  • Neuromuscular Scoliosis
  • Adolescent Idiopathic Scoliosis

Eligibility

Eligible Ages
Between 10 Years and 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Diagnosis of Adolescent Idiopathic Scoliosis (AIS) or neuromuscular scoliosis - Undergoing Posterior Spinal Fusion (PSF) Surgery

Exclusion Criteria

  • Patients with forms of scoliosis other than AIS or NM Scoliosis. - Patients undergoing a spinal deformity correction surgery other than Posterior Spinal Fusion Surgery - Allergy or other contraindication to erector spinae plane block (ESPB) with Ropivacaine patients who are taking pre-operative opioids

Study Design

Phase
Phase 3
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Treatment
Masking
Single (Participant)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
ESPB with Ropivacaine + standard postoperative pain protocol 		Erector spinae plan block (ESPB) with Ropivacaine and standard postoperative pain protocol
  • Drug: Ropivacaine Hydrocloride
    This drug is approved as a local anesthetic.
No Intervention
No ESPB + standard postoperative pain protocol 		No erector spinae plane block (ESPB) or type of injection and standard posteropative pain protocol

Recruiting Locations

University of California San Francisco
San Francisco, California 94158
Contact:
Tripta Rughwani
415-353-4701
tripta.rughwani@ucsf.edu

More Details

Status
Recruiting
Sponsor
University of California, San Francisco

Study Contact

Tripta Rughwani
415-353-4701
tripta.rughwani@ucsf.edu